An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses
No Thumbnail Available
Files
There are no files associated with this item.
Date
1998
Authors
André, Patrice
Klenerman, Paul
Giuli, Rita de
Booth, Bruce L.
Cerundolo, Vincenzo
Bonneville, Marc
Jotereau, Francine
Zinkernagel, Rolf M.
Lotteau, Vincent
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
URI (citable link)
DOI (citable link)
International patent number
Link to the license
EU project number
Project
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published in
Proceedings of the National Academy of Sciences ; 95 (1998), 22. - pp. 13120-13124. - ISSN 0027-8424
Abstract
Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis virus and treated with the HIV-1 protease inhibitor ritonavir a marked inhibition of antiviral cytotoxic T lymphocyte (CTL) activity and impaired major histocompatibility complex class I-restricted epitope presentation in the absence of direct effects on lymphocytic choriomeningitis virus replication. A potential molecular target was found: ritonavir selectively inhibited the chymotrypsin-like activity of the 20S proteasome. In view of the possible role of T cell-mediated immunopathology in AIDS pathogenesis, the two mechanisms of action (i.e., reduction of HIV replication and impairment of CTL responses) may complement each other beneficially. Thus, the surprising ability of ritonavir to block the presentation of antigen to CTLs may possibly contribute to therapy of HIV infections but potentially also to the therapy of virally induced immunopathology, autoimmune diseases, and transplantation reactions.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
ANDRÉ, Patrice, Marcus GRÖTTRUP, Paul KLENERMAN, Rita de GIULI, Bruce L. BOOTH, Vincenzo CERUNDOLO, Marc BONNEVILLE, Francine JOTEREAU, Rolf M. ZINKERNAGEL, Vincent LOTTEAU, 1998. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. In: Proceedings of the National Academy of Sciences. 95(22), pp. 13120-13124. ISSN 0027-8424. Available under: doi: 10.1073/pnas.95.22.13120BibTex
@article{Andre1998inhib-22240, year={1998}, doi={10.1073/pnas.95.22.13120}, title={An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses}, number={22}, volume={95}, issn={0027-8424}, journal={Proceedings of the National Academy of Sciences}, pages={13120--13124}, author={André, Patrice and Gröttrup, Marcus and Klenerman, Paul and Giuli, Rita de and Booth, Bruce L. and Cerundolo, Vincenzo and Bonneville, Marc and Jotereau, Francine and Zinkernagel, Rolf M. and Lotteau, Vincent} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/22240"> <dc:contributor>Cerundolo, Vincenzo</dc:contributor> <dc:contributor>Jotereau, Francine</dc:contributor> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/22240"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Booth, Bruce L.</dc:contributor> <dc:creator>Giuli, Rita de</dc:creator> <dcterms:abstract xml:lang="eng">Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis virus and treated with the HIV-1 protease inhibitor ritonavir a marked inhibition of antiviral cytotoxic T lymphocyte (CTL) activity and impaired major histocompatibility complex class I-restricted epitope presentation in the absence of direct effects on lymphocytic choriomeningitis virus replication. A potential molecular target was found: ritonavir selectively inhibited the chymotrypsin-like activity of the 20S proteasome. In view of the possible role of T cell-mediated immunopathology in AIDS pathogenesis, the two mechanisms of action (i.e., reduction of HIV replication and impairment of CTL responses) may complement each other beneficially. Thus, the surprising ability of ritonavir to block the presentation of antigen to CTLs may possibly contribute to therapy of HIV infections but potentially also to the therapy of virally induced immunopathology, autoimmune diseases, and transplantation reactions.</dcterms:abstract> <dc:creator>Booth, Bruce L.</dc:creator> <dc:creator>Lotteau, Vincent</dc:creator> <dc:language>eng</dc:language> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Klenerman, Paul</dc:contributor> <dcterms:bibliographicCitation>Proceedings of the National Academy of Sciences of the United States of America ; 95 (1998), 22. - S. 13120-13124</dcterms:bibliographicCitation> <dc:contributor>André, Patrice</dc:contributor> <dc:contributor>Giuli, Rita de</dc:contributor> <dc:creator>Zinkernagel, Rolf M.</dc:creator> <dcterms:title>An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses</dcterms:title> <dc:contributor>Gröttrup, Marcus</dc:contributor> <dc:creator>Jotereau, Francine</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-03-28T12:38:52Z</dc:date> <dc:creator>André, Patrice</dc:creator> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:contributor>Zinkernagel, Rolf M.</dc:contributor> <dc:contributor>Lotteau, Vincent</dc:contributor> <dc:rights>terms-of-use</dc:rights> <dcterms:issued>1998</dcterms:issued> <dc:creator>Klenerman, Paul</dc:creator> <dc:contributor>Bonneville, Marc</dc:contributor> <dc:creator>Gröttrup, Marcus</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-03-28T12:38:52Z</dcterms:available> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Cerundolo, Vincenzo</dc:creator> <dc:creator>Bonneville, Marc</dc:creator> </rdf:Description> </rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
No